Literature DB >> 6451334

In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.

A L Barry, C Thornsberry, R N Jones, T L Gavan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6451334     DOI: 10.3949/ccjm.47.4.311

Source DB:  PubMed          Journal:  Cleve Clin Q        ISSN: 0009-8787


× No keyword cloud information.
  8 in total

1.  In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.

Authors:  M D Lyon; K R Smith; M S Saag; G A Cloud; C G Cobbs
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Cross-resistance and cross-susceptibility between fluoroquinolone agents.

Authors:  A L Barry; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

3.  Clinical comparison of piperacillin and cefoxitin in patients with bacteriologically confirmed infections.

Authors:  R V McCloskey
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

4.  Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones; T L Gavan
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

Review 5.  Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.

Authors:  R N Jones
Journal:  Infection       Date:  1985       Impact factor: 3.553

6.  In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.

Authors:  A J Matzkowitz; A L Baltch; R P Smith; N T Sutphen; M C Hammer; J V Conroy
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

7.  Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks.

Authors:  A L Barry; R N Jones; C Thornsberry; T L Gavan
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

8.  Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.

Authors:  J T Downs; V T Andriole; J L Ryan
Journal:  Yale J Biol Med       Date:  1986 Jan-Feb
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.